Ad
related to: merck pharmaceuticals
Search results
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 1 day agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 2 days agoMerck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...
Merck to Acquire EyeBio
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours agoThe analysts forecast a margin expansion of 40 basis points in 2024-28, compared with market expectations 170 basis points. Innovation catalyzers for the...
US Duo Takes On Merck's $3B Acquisition Of EyeBio | Law.com International
Law.com· 19 hours agoSkadden Arps Slate Meagher & Flom and Gibson Dunn & Crutcher have taken on lead roles in New...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 1 day agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 2 days agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 1 day agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 2 days agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
